Article

President-elect Dr. Wilkinson focuses on lifelong learning, physician issues

In his president-elect address, C.P. Wilkinson, MD, vowed to provide continued support for the AAO's mission to advance the lifelong learning and professional interests of ophthalmologists to ensure that the public can obtain the best eye care.

In his president-elect address, C.P. Wilkinson, MD, vowed to provide continued support for the AAO's mission to advance the lifelong learning and professional interests of ophthalmologists to ensure that the public can obtain the best eye care.

Among his objectives is to maintain and strengthen the AAO's influence upon health policy in the United States. Changes are coming and the meaningful performances of the academy staffs in Washington, DC, and the state affairs division must continue in the months and years ahead, he said.

"This is a critical issue," said Dr. Wilkinson during the AAO's opening session Sunday morning.

"Regarding lifelong learning, I hope to emphasize and promote the academy's pivotal role in education," he said.

A remarkable evolution in education has occurred in the AAO's existence over the past century. The worldwide distribution of AAO educational materials is vital, as physicians remain up to date through continuing education.

"CME and recertification are pertinent topics for these times," Dr. Wilkinson said. "The end result is that more patients will receive the best possible eye care."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.